Globus Medical (NYSE: GMED) reported Q1 EPS of $1.12, $0.20 better than the analyst estimate of $0.92. Revenue for the quarter came in at $759.85 million versus the consensus estimate of $740.34 million.

GUIDANCE:

Globus Medical sees FY2026 EPS of $4.70-$4.80, versus the consensus of $4.47. Globus Medical sees FY2026 revenue of $3.18-3.22 billion, versus the consensus of $3.2 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.